Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10334291 | 0.91 | ALDH1A1 (0.41) | ALDH1A1TSHRALOX15CYP2D6CYP2C19 | |
| SCHEMBL13572509 | 0.91 | TSHR (0.41) | ALDH1A1TSHRPPARDALOX15MAPT | |
| SCHEMBL2238293 | 0.78 | TSHR (0.43) | ALDH1A1TSHRPPARDALOX15MAPT | |
| SCHEMBL18196371 | 0.77 | TSHR (0.36) | ALDH1A1TSHRPPARDMAPTNPSR1 | |
| SCHEMBL7166415 | 0.76 | ALDH1A1 (0.38) | ALDH1A1TSHRPPARDCYP2D6CYP2C19 | |
| SCHEMBL16830099 | 0.76 | ALDH1A1 (0.44) | ALDH1A1TSHRALOX15CYP2D6CYP2C19 | |
| SCHEMBL12674418 | 0.74 | PPARD (0.47) | ALDH1A1TSHRPPARDMAPTTDP1 | |
| SCHEMBL8196995 | 0.74 | ALDH1A1 (0.41) | ALDH1A1EGLN1 | |
| SCHEMBL14955789 | 0.72 | THRB (0.44) | ALDH1A1TSHRPPARDMAPTLMNA | |
| SCHEMBL6264155 | 0.72 | ALDH1A1 (0.35) | ALDH1A1TSHRCYP2D6CYP2C19MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170172855-A1 | Compositions With Controlled Network Structure | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-22 | — | — | US | disclosed |
| US-20170172855-A1 | Compositions With Controlled Network Structure | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170172855-A1 | Compositions With Controlled Network Structure | NCLN, RAD51, SMCHD1 | ALDH1A1 2901/4885TSHR 4627/4885PPARD 4003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.